200 related articles for article (PubMed ID: 29862563)
21. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
Horna P; Moscinski LC; Sokol L; Shao H
Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
[TBL] [Abstract][Full Text] [Related]
22. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
23. miRNA in mycosis fungoides and skin inflammation.
Persson JL
APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
[TBL] [Abstract][Full Text] [Related]
24. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
[TBL] [Abstract][Full Text] [Related]
25. Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.
Miyagaki T; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Fujita H; Yoshizaki A; Asano Y; Sato S
Acta Derm Venereol; 2017 May; 97(5):586-592. PubMed ID: 28119994
[TBL] [Abstract][Full Text] [Related]
26. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
[TBL] [Abstract][Full Text] [Related]
27. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
[TBL] [Abstract][Full Text] [Related]
28. Overview of Cutaneous T-Cell Lymphomas.
Larocca CA; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
[TBL] [Abstract][Full Text] [Related]
29. [Comparative analysis of the expression of cell adhesion molecules in cutaneous T-cell lymphomas (mycosis fungoides/Sézary syndrome) and inflammatory skin diseases].
López-Lerma I; Estrach MT
Actas Dermosifiliogr; 2010 Dec; 101(10):866-77. PubMed ID: 21159263
[TBL] [Abstract][Full Text] [Related]
30. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.
Mao X; Lillington D; Scarisbrick JJ; Mitchell T; Czepulkowski B; Russell-Jones R; Young B; Whittaker SJ
Br J Dermatol; 2002 Sep; 147(3):464-75. PubMed ID: 12207585
[TBL] [Abstract][Full Text] [Related]
32. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
Döbbeling U
G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
Bobrowicz M; Fassnacht C; Ignatova D; Chang YT; Dimitriou F; Guenova E
Int Arch Allergy Immunol; 2020; 181(10):733-745. PubMed ID: 32690848
[TBL] [Abstract][Full Text] [Related]
34. A new molecular paradigm in mycosis fungoides and Sézary syndrome.
Elenitoba-Johnson KS; Wilcox R
Semin Diagn Pathol; 2017 Jan; 34(1):15-21. PubMed ID: 28024703
[TBL] [Abstract][Full Text] [Related]
35. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome.
Scarisbrick JJ; Woolford AJ; Calonje E; Photiou A; Ferreira S; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Mar; 118(3):493-9. PubMed ID: 11874489
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of T-cell receptor beta genes in cutaneous T-cell lymphoma reveals Jbeta1 bias.
Morgan SM; Hodges E; Mitchell TJ; Harris S; Whittaker SJ; Smith JL
J Invest Dermatol; 2006 Aug; 126(8):1893-9. PubMed ID: 16741518
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous T-cell lymphoma: a review.
Winkler CF; Bunn PA
Crit Rev Oncol Hematol; 1983; 1(1):49-92. PubMed ID: 6083835
[TBL] [Abstract][Full Text] [Related]
38. [Current pathogenetic aspects of Sézary syndrome and mycosis fungoides].
Dummer R; Willers J; Döbbeling U; Burg G
Hautarzt; 2001 Mar; 52(3):189-92. PubMed ID: 11284062
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.
Krejsgaard T; Odum N; Geisler C; Wasik MA; Woetmann A
Leukemia; 2012 Mar; 26(3):424-32. PubMed ID: 21904385
[TBL] [Abstract][Full Text] [Related]
40. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.
Nevet MJ; Zuckerman T; Sahar D; Bergman R
Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
